EQR
40
-2
MKC
63
-2
NRG
40
3
XOM
37
-2
PBI
66
3
NKE
42
6
IP
54
-2
M
50
-3
DG
21
-6
AMP
54
2
TAP
61
-3
HUM
34
-7
BBY
48
2
BK
68
-3
FFIV
70
3
XYL
41
-13
APA
37
2
FTI
73
4
BA
65
2
EOG
36
2
EQR
40
-2
MKC
63
-2
NRG
40
3
XOM
37
-2
PBI
66
3
NKE
42
6
IP
54
-2
M
50
-3
DG
21
-6
AMP
54
2
TAP
61
-3
HUM
34
-7
BBY
48
2
BK
68
-3
FFIV
70
3
XYL
41
-13
APA
37
2
FTI
73
4
BA
65
2
EOG
36
2
Financhill
Back

Shanghai Pharmaceuticals Holding 10K Form

Sell
32

SHPMF
Shanghai Pharmaceuticals Holding

Last Price:
1.27
Seasonality Move:
3.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SHPMF News And Ratings

See the #1 stock for the next 7 days that we like better than SHPMF

SHPMF Financial Statistics

Sales & Book Value

Annual Sales: $36.8B
Cash Flow: $-134.27M
Price / Cash Flow: 0
Annual Sales: $2.73
Price / Book: 0.47

Profitability

EPS (TTM): 0.15070
Net Income (TTM): $561.48M
Gross Margin: $4.43B
Return on Equity: 4.92%
Return on Assets: 1.85%

Shanghai Pharmaceuticals Holding Earnings Forecast

Key Shanghai Pharmaceuticals Holding Financial Ratios

  • The Gross Profit Margin over the past 31 years for SHPMF is 12.04%.
  • The Selling, General & Administrative Expenses for SHPMF have been equal to 4.19% of Gross Profit Margin.
  • The Research & Development expenses have been 0.85% of Revenue.
  • The Interest Expense is 44.15% of Operating Income.
  • The Net Earning history of SHPMF is 1.45% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 18 years.

Shanghai Pharmaceuticals Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: SHPMF
Website: sphchina.com

Debt

Debt-to-Equity Ratio: 0.68
Current Ratio: 1.34
Quick Ratio: 1.02

Price-to-Earnings

Trailing P/E Ratio: 8.81
Forward P/E Ratio: 0

SHPMF Technical Analysis vs Fundamental Analysis

Sell
32
Shanghai Pharmaceuticals Holding (SHPMF) is a Sell

Is Shanghai Pharmaceuticals Holding a Buy or a Sell?